Point-of-Care solution for osteoporosis management

The aim of this innovation mandate is to address the remaining scientific and technological challenges in the previously developed platform for measuring biomarkers for the production and breakdown of bone tissue in blood and to investigate whether there is a viable case for this platform on the market. through a spin-off company. The platform consists of a disposable cartridge containing the functionalized measuring electrodes and a reusable read-out device that contains the necessary electrical and mechanical systems to measure the concentration of these biomarkers in blood that is placed on the cartridge.